Bond Screener
Genzyme
LEI 549300ZNNO34O8GXUE47
Organization name
Genzyme Corporation
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
-
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Genzyme Corporation, a biotechnology company, engages in the discovery and development of products and services primarily in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases, and endocrinology worldwide. Genzyme Corporation operates as a subsidiary of Sanofi.
|
General information
-
Organization nameGenzyme Corporation
-
Organization statusOperating organization
-
Address500 Kendall Street Cambridge, USA, 02142
-
Site
Stocks
General information
-
Organization nameGenzyme Corporation
-
Organization statusOperating organization
-
Address500 Kendall Street Cambridge, USA, 02142
-
Site
Codes
-
LEI549300ZNNO34O8GXUE47
-
SIC2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
-
NACE*** ***
-
NAICS*** ***
-
CIK0000732485
